GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. (Q40334208)
Jump to navigation
Jump to search
scientific article published on February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. |
scientific article published on February 2006 |
Statements
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system (English)
D Dondi
C Festuccia
M Piccolella
M Bologna